Li Kang Biomedical Co (6242.TWO) Stock Price
Li Kang Biomedical Co Price
Revenue at Li Kang Biomedical Co has contracted by 2.1% per year over the past 19 years to 589.21 M TWD. Earnings per share have grown at 4.7% per year over the last 10 years. Li Kang Biomedical Co's net margin stands at 14.2%, broadly stable from 13.3% several years earlier. Li Kang Biomedical Co currently offers a dividend yield of about 5.91%. The payout ratio is around 76% of earnings. The dividend has grown at 16.6% per year over the past 3 years.
Li Kang Biomedical Co stock price
Li Kang Biomedical Co business model & stock analysis
Frequently asked questions about Li Kang Biomedical Co
Converted at the current exchange rate, the Li Kang Biomedical Co share trades at 0.95 EUR (33.85 TWD).
The revenue cannot currently be calculated for Li Kang Biomedical Co.
The profit cannot currently be calculated for Li Kang Biomedical Co.
The P/E ratio cannot be calculated for Li Kang Biomedical Co at the moment.
The P/S cannot be calculated for Li Kang Biomedical Co currently.
The Eulerpool Quality Score for Li Kang Biomedical Co is 4/10.
The ISIN of Li Kang Biomedical Co is TW0006242001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Li Kang Biomedical Co is 6242.TWO. The ticker symbol is used to trade Li Kang Biomedical Co shares on the stock exchange.
Li Kang Biomedical Co stock
Li Kang Biomedical Co Peer Group
Li Kang Biomedical Co FIGI
All fundamentals and in-depth analysis of Li Kang Biomedical Co
Our stock analysis for Li Kang Biomedical Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Li Kang Biomedical Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.